Praxis Precision Medicines (PRAX) Assets Average (2020 - 2026)

Praxis Precision Medicines' Assets Average history runs 7 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• In Q1 2026, Assets Average rose 149.32% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (up 149.32% YoY), while the FY2025 annual figure was $710.5 million, up 148.84% from the prior year.
• Assets Average was $1.2 billion for Q1 2026 at Praxis Precision Medicines, up from $667.1 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.2 billion in Q1 2026 to a low of $97.3 million in Q4 2023.
• Historically, Assets Average has averaged $343.0 million across 5 years, with a median of $266.1 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Assets Average tumbled 59.89% in 2023, then jumped 361.99% in 2024.
• A 5-year view of Assets Average shows it stood at $126.0 million in 2022, then decreased by 22.76% to $97.3 million in 2023, then surged by 361.99% to $449.7 million in 2024, then soared by 48.36% to $667.1 million in 2025, then jumped by 79.73% to $1.2 billion in 2026.
• The last three Assets Average figures came in at $1.2 billion (Q1 2026), $667.1 million (Q4 2025), and $424.6 million (Q3 2025), per Business Quant data.